Project Grant HT94252310150
Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $6.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $2.67M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2029. The project, titled "Identifying Pathways of Progression of Acute Pancreatitis to Recurring Acute Pancreatitis and Chronic Pancreatitis," represents a four-year research initiative focused on understanding the disease progression...
- This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $6.14 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2028. The award supports the therapeutic development of noncoding RNA drug TY1 for the treatment of scleroderma. This research initiative aligns with the DHA's mission to advance biomedical innovation for military service members and the broader...
- This Project Grant award, totaling $2,685,519.00, was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant supports advanced biomedical research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and explore methods to eradicate them. This 4-year research project, running from July 1, 2025 to June 30, 2029, aims to...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $974,043 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of September 1, 2025, and a completion date of August 31, 2029. The award funds research titled "Early Cardiac Biomarkers of Inflammation and Remodeling in DMD" (Duchenne muscular dystrophy), to be conducted at the medical center's West Hollywood, California...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $501,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 15, 2025, with a completion date of July 14, 2027. The research project, titled "Large Oncosomes as Drivers of Prostate Cancer Bone Metastasis," is being conducted at the institution's West Hollywood, California location. This award supports biomedical...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $1.252 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2025 through September 29, 2029. The award supports research into the structure, function, and inhibition of ONECUT2, a driver of prostate cancer development and progression. This research initiative aligns with the DHA's mission to advance biomedical...
- The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $997,343 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis, with performance conducted at the organization's West Hollywood, California facility. This three-year research initiative applies...